Results 41 to 50 of about 4,789,649 (215)

Aspects of surgical treatment of primary hyperparathyroidism

Acta Medica Leopoliensia, 2019
Aim. To evaluate the results of surgical treatment of patients with primary hyperparathyroidism. Material and methods. The work is based on retrospective and prospective analysis of the results of treatment among 81 patients with typical clinical ...
R.T. Kuzenko, A.O. Vaсeba, O.S. Gavrylyuk, M.B. Fedorkiv   +3 more
doaj   +1 more source

[Primary hyperparathyroidism in Russia according to the registry].

Problemy Endokrinologii, 2019
BACKGROUND There are no large-scale epidemiological studies on primary hyperparathyroidism (PHPT) in Russia. The high prevalence of the disease, the high risk of disability and death in this cohort of patients requires the study of the epidemiological ...
N. Mokrysheva, S. Mirnaya, E. Dobreva, I. Maganeva, E. Kovaleva, J. Krupinova, I. Kryukova, L. K. Tevosyan, Stanislav V. Lukyanov, N. V. Markina, I. Bondar, N. Г. Podprugina, Irina A. Ignatieva, O. Shabelnikova, A. Dreval, M. B. Antsiferov, G. Mel’nichenko, I. Dedov   +17 more
semanticscholar   +1 more source

Primary hyperparathyroidism clinical features on endocrinology in-patients clinic

Терапевтический архив, 2018
Aim. The analysis clinical features of primary hyperparathyroidism on endocrinology in-patients clinic. Materials and methods. Open retrospective study, included data of patients who were hospitalized at Kirov Regional Hospital with primary ...
I E Sapozhnikova
doaj   +1 more source

18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients

European Journal of Nuclear Medicine and Molecular Imaging, 2018
PurposeIn this prospective study we compared the accuracy of 18F-fluorocholine PET/CT with that of 99mTc-MIBI or99mTc-tetrofosmin SPECT/CT in the preoperative detection of parathyroid adenoma in patients with primary hyperparathyroidism. We also assessed
M. Beheshti, L. Hehenwarter, Zeinab Paymani, G. Rendl, L. Imamovic, Rupert Rettenbacher, O. Tsybrovskyy, W. Langsteger, C. Pirich   +8 more
semanticscholar   +1 more source

Primary hyperparathyroidism

Best Practice & Research Clinical Rheumatology, 2020
Primary hyperparathyroidism (PHPT) is a condition that affects calcium metabolism due to parathyroid hormone (PTH) hypersecretion leading to hypercalcemia. Manifestations have changed over time, from a symptomatic disease with bone pain, fractures, nephrolithiasis, and muscle weakness, to a condition that is mainly asymptomatic (80-90%).
Júlia V, Oberger Marques, Carolina A, Moreira   +1 more
openaire   +5 more sources

Comparison of first- and second-line imaging diagnostics (ultrasound + scintigraphy and PET + 4DCT) in visualizing parathyroid glands in primary hyperparathyroidism including ectopic foci

Journal of Education, Health and Sport
Introduction: Primary hyperparathyroidism is an endocrine disorder that causes disturbances in calcium and phosphorus metabolism in the human body.
Laura Loryś, Klaudia Klimczak, Kamila Budzyńska, Marcin Narloch, Stanisław Kasprzak, Karolina Kasprzak, Jakub Kamiński, Norbert Kandefer   +7 more
doaj   +1 more source

Diabetes mellitus, chronic pancreatitis and primary hyperparathyroidism: is there a connection?

Сахарный диабет, 2019
Hyperparathyroidism is a relatively frequent condition characterized by hypersecretion of parathyroid hormone. There are several forms of primary hyperparathyroidism. Each form affects its target region.
Anna M. Gorbacheva, Nataliya V. Zaytseva
doaj   +1 more source

Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus

Osteoporosis International, 2016
The purpose of this review is to assess the most recent evidence in the management of primary hyperparathyroidism (PHPT) and provide updated recommendations for its evaluation, diagnosis and treatment. A Medline search of "Hyperparathyroidism.
Aliya A. Khan, D. Hanley, R. Rizzoli, J. Bollerslev, J. Young, L. Rejnmark, R. Thakker, P. D'amour, Terri Paul, S. V. Uum, M. Shrayyef, David Goltzman, S. Kaiser, N. Cusano, R. Bouillon, L. Mosekilde, A.Y.H Kung, S. D. Rao, S. Bhadada, B. Clarke, Jian-min Liu, Q. Duh, E. Lewiecki, F. Bandeira, R. Eastell, C. Marcocci, S. Silverberg, R. Udelsman, K. Davison, J. T. Potts, M. Brandi, J. Bilezikian   +31 more
semanticscholar   +1 more source

Optogenetic‐Controlled iPSC‐Based Vaccines for Prophylactic and Therapeutic Tumor Suppression in Mice

Advanced Science, EarlyView.
This study develops an a red/far‐red light‐controlled iPSC‐based vaccines (RIVA) based on the chimeric photosensory protein FnBphP and its interaction partner LDB3 for cancer immunotherapy. The RIVA preserves the multiple intrinsic tumor antigens of iPSCs and enables optogenetic control of the expression of the immune adjuvant type I interferon β under
Longliang Qiao, Lingxue Niu, Zhihao Wang, Di Dai, Shasha Tang, Xiaoding Ma, Zhenqiang Deng, Guiling Yu, Yang Zhou, Tao Yan, Xingwan Liu, Deqiang Kong, Linfeng Hu, Xiang Li, Junwei Zhao, Fengfeng Cai, Meiyan Wang, Haifeng Ye   +17 more
wiley   +1 more source

Intraoperative Parathyroid Hormone Monitoring in the Surgical Management of Sporadic Primary Hyperparathyroidism [PDF]

Endocrinology and Metabolism, 2019
Intraoperative parathyroid hormone monitoring (IPM) has been shown to be a useful adjunct during parathyroidectomy to ensure operative success at many specialized medical centers worldwide. Using the Miami or “>50% intraoperative PTH drop” criterion, IPM
Zahra F. Khan, John I. Lew
doaj   +1 more source